EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Sodium-iodide symporter and its related solute carriers in thyroid cancer

Zhongqin Gong, Minghui Wei, Alexander C Vlantis, Jason Y K Chan, C Andrew Van Hasselt, Dongcai Li, Xianhai Zeng, Lingbin Xue, Michael C F Tong, George G Chen iD

Journal of Endocrinology · 2024

DOI: 10.1530/joe-23-0373 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Endocrinology, 2024. Verfasst von Zhongqin Gong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Symporters. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 85 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The solute carrier (SLC) family is a large group of membrane transport proteins. Their dysfunction plays an important role in the pathogenesis of thyroid cancer. The most well-known SLC is the sodium-iodide symporter (NIS), also known as sodium/iodide co-transporter or solute carrier family 5 member 5 (SLC5A5) in thyroid cancer. The dysregulation of NIS in thyroid cancer is well documented. The role of NIS in the uptake of iodide is critical in the treatment of thyroid cancer, radioactive iodide (RAI) therapy in particular. In addition to NIS, other SLC members may affect the autophagy, proliferation, and apoptosis of thyroid cancer cells, indicating that an alteration in SLC members may affect different cellular events in the evolution of thyroid cancer. The expression of the SLC members may impact the uptake of chemicals by the thyroid, suggesting that targeting SLC members may be a promising therapeutic strategy in thyroid cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsSymportersHumansIodidesSodium-Iodide Symporters

Stichwörter der Autor:innen

NISSLC5A5iodidesolute carrier familythyroid cancer

Substanzen

IodidesSymportersSodium-Iodide Symporters

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Head and Neck Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.
  • Department of Head & Neck Surgery, Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center, Shenzhen, China.
  • Shenzhen Key Laboratory of ENT, Institute of ENT & Longgang ENT Hospital, Shenzhen, China.

ORCID-Profile: George G Chen

Zitieren

APA

Gong, Z., Wei, M., Vlantis, A. C., Chan, J. Y. K., Van Hasselt, C. A., Li, D., Zeng, X., Xue, L., Tong, M. C. F., & Chen, G. G. (2024). Sodium-iodide symporter and its related solute carriers in thyroid cancer. Journal of Endocrinology. https://doi.org/10.1530/joe-23-0373

Vancouver

Gong Z, Wei M, Vlantis AC, Chan JYK, Van Hasselt CA, Li D, et al. Sodium-iodide symporter and its related solute carriers in thyroid cancer. Journal of Endocrinology. 2024. doi:10.1530/joe-23-0373

BibTeX
@article{Gong2024,
  author = {Gong, Zhongqin and Wei, Minghui and Vlantis, Alexander C and Chan, Jason Y K and Van Hasselt, C Andrew and Li, Dongcai and Zeng, Xianhai and Xue, Lingbin and Tong, Michael C F and Chen, George G},
  title = {Sodium-iodide symporter and its related solute carriers in thyroid cancer},
  journal = {Journal of Endocrinology},
  year = {2024},
  doi = {10.1530/joe-23-0373}
}
Kostenlos starten →